Auditory Dysfunction and Migraine Link Explained

**Key Takeaways**
* Migraine is linked to a range of auditory problems, with 15-49% of patients experiencing symptoms like tinnitus, hyperacusis, or hearing loss.
* The connection is explained by a three-axis model: vascular/fluid issues in the inner ear, local neurochemical imbalances, and central brain sensitization.
* This model suggests treatments should target the specific pathway involved, moving beyond generic approaches.
* Early identification of auditory symptoms in migraine patients can lead to more precise, cross-disciplinary care.

A 2026 review in the *Journal of Neurology* establishes that migraine is far more than a headache disorder; it is a systemic condition that frequently disrupts the auditory system. The paper, led by researchers from Huazhong University of Science and Technology, consolidates data showing that auditory dysfunction is a common, yet often under-recognized, feature of migraine.

The statistics are striking. Epidemiological data indicates that between **15% and 49%** of people with migraine report comorbid auditory symptoms. Furthermore, nearly two-thirds show objective abnormalities on auditory electrophysiological tests. These symptoms include sensorineural hearing loss, tinnitus, and hyperacusis—a heightened sensitivity to everyday sounds.

### The Three-Axis Model: How Migraine Disrupts Hearing

The research team, including Wandi Xu, Ni Zhai, and Jingyu Chen, proposes that the link between migraine and auditory dysfunction operates across three interacting biological pathways. This model moves beyond simple comorbidity to explain potential mechanisms.

**1. Anatomical and Vascular Vulnerabilities.** The inner ear is highly sensitive to changes in blood flow and fluid pressure. The review suggests that migraine-related vascular events, such as localized microvascular ischemia (reduced blood flow), can directly injure the delicate structures of the cochlea. Furthermore, aberrant exchanges in the fluids that bathe the brain and inner ear may disrupt the cochlear microenvironment.

**2. Local Neurochemical Imbalance.** Within the inner ear itself, migraine processes can create a toxic local environment. The paper highlights **glutamate excitotoxicity**—where an excess of this neurotransmitter damages hair cells and auditory neurons. Signaling by neuropeptides like CGRP (calcitonin gene-related peptide), a key player in migraine pain, and activation of local immune responses further contribute to inner ear stress and dysfunction.

**3. Central Sensitization and Network Plasticity.** This is considered a core component. Migraine is a state of heightened central nervous system sensitivity. This “central sensitization” facilitates maladaptive plasticity in brain networks that process sound. The review points to two key concepts: **impaired efferent gating** (where the brain’s ability to filter out irrelevant sound signals is weakened) and **thalamocortical dysrhythmia** (where abnormal rhythmic activity between the thalamus and cortex generates phantom perceptions like tinnitus).

### From Mechanism to Management: A Targeted Therapeutic Framework

The value of this three-axis model is its direct implication for treatment. Instead of a one-size-fits-all approach, the review categorizes strategies by their specific clinical target.

**Blocking Upstream Migraine Pathways.** This involves using established or emerging migraine medications to prevent the cascade before it affects the ear. This could include CGRP monoclonal antibodies or gepants, which may mitigate the neurochemical and vascular events that secondarily harm auditory function.

**Protecting the Cochlear Microenvironment.** Therapies here would aim to improve inner ear resilience. This might involve investigating agents that reduce glutamate excitotoxicity, modulate local inflammation, or stabilize fluid and ionic balances within the cochlea.

**Correcting Central Hypersensitivity.** For auditory symptoms like tinnitus and hyperacusis that are maintained by central brain changes, treatments focused on neuromodulation are relevant. This aligns with approaches like cognitive behavioral therapy (CBT), tinnitus retraining therapy (TRT), and potentially non-invasive brain stimulation techniques designed to recalibrate dysfunctional neural networks. This understanding of central factors shares conceptual ground with research on other conditions, such as the overlap in neural mechanisms seen in PTSD and tinnitus.

### Practical Implications for Patients and Clinicians

For patients, this research validates that their auditory symptoms are likely a genuine part of their migraine disorder, not an unrelated or psychological issue. It underscores the importance of comprehensive audiological evaluation for individuals with migraine, especially if they notice changes in their hearing, sound tolerance, or the onset of tinnitus.

For clinicians, the framework encourages a more integrated, cross-disciplinary approach. Neurologists and headache specialists should consider routine screening for auditory complaints. Otolaryngologists and audiologists should view migraine as a potential contributing factor in patients presenting with idiopathic hearing loss, tinnitus, or hyperacusis, particularly if other migraine features are present. This integrated view of auditory health is a growing focus, as seen in broader discussions on integrated auditory health.

The review also highlights a significant gap: variable audiological assessment protocols and dispersed therapeutic data. There is a clear need for standardized guidelines to evaluate and track auditory dysfunction in migraine populations within clinical trials and practice.

**Source:** This article is based on the review “Migraine and auditory dysfunction: beyond comorbidity” by Xu et al., published in *J Neurol* (2026). You can access the full paper via its PMID 42371148 or DOI: 10.1007/s00415-026-13957-0.

*This evidence-based summary is intended for informational purposes. Always consult a qualified healthcare professional for diagnosis and treatment.*